Close

News

Eisai Inc. Received U.S Food and Drug Administration for Eisai’s Halaven Injection

Eisai Inc. announced that the United States Food and Drug Administration (FDA) has approved Halavenâ„¢ (eribulin mesylate) Injection for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment...

MorphoSys Launches New Antibody Technology

MorphoSys AG has launched a novel antibody optimization platform called arYla. The company plans to use arYla to accelerate antibody optimization, with the goal of generating superior therapeutic and diagnostic candidates faster and more cost-effectively than is currently possible,...

Biomoda Selects Quintiles To Refine Lung Cancer Tests

Biomoda, Inc. has allied with Quintiles Global Central Laboratories to help refine the automated image recognition system for measuring the photon emission rate and cell morphology of CyPath-stained cells to detect early stage lung cancer. Biomoda’s...

Boehringer Ingelheim entered into a collabration agreement with VTU Technology

Boehringer Ingelheim, a global leader in biopharmaceutical contract development and manufacture, and VTU Technology, a leading supplier of exclusive technologies and comprehensive services for the development of high-performance Pichia pastoris protein expression strains, announced today that they have entered...

Columbia Asia performs its first stem cell transplant

Columbia Asia Hospital - Yeshwanthpur in Bangalore performed its first stem cell transplant recently. The Times of India featured the procedure this week and described how a 44-year-old Swiss man was unable to walk without help until he came...

IntegenX Launches the Apollo 324 System for Automated DNA

IntegenX Inc(IXI) at the 60th Annual American Society of Human Genetics Meeting announced the launch of their Apollo 324 System, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing. The system can prepare...

Merck To Present Innovative Products for Displays at the FPD International in Makuhari (Japan)

Merck KGaA announced today that it will be exhibiting at the FPD International, one of the leading events for the flat panel display industry, from November 10 to 12, 2010 in Makuhari / Chiba, (Japan). The ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read